ROCKVILLE, Md., May 22, 2024 /PRNewswire/ — I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024.
Jefferies Global Healthcare Conference
Presentation Time
Wednesday, June 5 at 9:30 a.m. EST
Presenters
Raj Kannan, CEO; Louie Naumovski, Interim CMO
Webcast link
Meetings
One-on-one and small group meetings: June 5, 2024
ManagementParticipants
Raj Kannan, CEO
Joe Skelton, CFO
Louie Naumovski, Interim CMO
Tyler Ehler, Senior Director, Investor Relations
The webcast will also be available under "Event Calendar" on I-Mab’s IR websiteat https://ir.i-mabbiopharma.com/
For more information, please contact your Jefferies representative.
About I-Mab
I-Mab (NASDAQ: IMAB) is a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and in San Diego, California. For more information, please visit https://ir.i-mabbiopharma.com/ and follow us on LinkedIn and X.
For more information, please contact:Tyler EhlerSenior Director, Investor RelationsIR@imabbio.com
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
